Patricia P. Gonzalez's most recent trade in Abbott Laboratories was a trade of 1,635 Common shares without par value done . Disclosure was reported to the exchange on April 25, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 1,635 | 6,919 (0%) | 0% | 0 | Common shares without par value | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 248 | 4,393 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 291 | 4,125 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 289 | 3,815 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 317 | 3,509 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 1,866 | 5,284 (0%) | 0% | 0 | Common shares without par value | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 290 | 3,174 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 299 | 2,870 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 340 | 2,557 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 302 | 2,206 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 1,816 | 3,418 (0%) | 0% | 0 | Common shares without par value | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 325 | 1,894 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 300 | 1,561 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 341 | 1,254 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 303 | 910 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 1,602 | 1,602 (0%) | 0% | 0 | Common shares without par value | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 278 | 603 | - | - | Stock Equivalent Units | |
Abbott Laboratories | Patricia P. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 88 | 88 | - | - | Stock Equivalent Units |